Sexually Transmitted Disease

Vaccine candidates for STD prevention and treatment reviewed

Published in Vaccine Weekly, February 26th, 2003

by Maria G. Essig, MS, ELS, senior medical writer - Despite encountering challenges such as broad antigenic heterogeneity of pathogenic microorganisms and poor immune-response stimulating features of vaccines designed to prevent and treat sexually transmitted diseases, progress in vaccine development has made great strides, according to researchers in France.

"Sexually transmitted diseases (STDs) are caused by organisms that infect the mucosal surfaces of the genitourinary tract," stated Mark A. Fletcher at Wyeth Vaccine Research in Paris. "In spite of its public health importance, current STD vaccine research lags behind work against pathogens that target another...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2003-02-26)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry